Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Breast Cancer
Caris Life Sciences embarks on 10K-sample breast cancer biomarker analysis project
By
LabPulse.com staff writers
Caris will perform comprehensive molecular characterization of TAILORx tissue samples.
October 25, 2024
Myriad Genetics enters 5 MRD test research collaborations
By
LabPulse.com staff writers
Precision medicine company Myriad Genetics has entered into five ongoing research collaborations aimed at studying the use of molecular residual disease (MRD) testing in breast cancer using Myriad's Precise MRD test.
October 9, 2024
University of Eastern Finland researchers develop algorithm for better breast cancer screening
By
LabPulse.com staff writers
Researchers at the University of Eastern Finland have developed an algorithm to improve mammogram density assessment, with the potential to increase screening accuracy.
August 23, 2024
Hologic acquires Endomag for $310M
By
LabPulse.com staff writers
Hologic has completed its acquisition of breast cancer surgery technologies developer Endomagnetics (Endomag) for approximately $310 million.
July 26, 2024
Researchers develop AI model for breast tumor staging
By
LabPulse.com staff writers
A team of researchers has created an artificial intelligence (AI) model that can identify the different stages of ductal carcinoma in situ, a preinvasive tumor that may progress to a lethal form of breast cancer.
July 25, 2024
AI model could prevent unnecessary treatment for breast cancer patients, says study
By
Matt Limb
Breast cancer patients could be spared unnecessary chemotherapy with the use of a new artificial intelligence (AI) tool that helps predict survival risk, say researchers.
November 30, 2023
Fragment of C. diff toxin shows preclinical promise as breast cancer treatment
By
Nick Paul Taylor
A fragment of a
Clostridium difficile
toxin could improve outcomes in patients with hard-to-treat forms of breast cancer, according to a paper published in
PLOS Biology
.
November 13, 2023
Genomic Health to pay $32.5M to settle False Claims Act allegations
By
LabPulse.com staff writers
Genomic Health, a subsidiary of Exact Sciences, has agreed to pay $32.5 million to settle allegations by the U.S. Department of Justice that it violated the False Claims Act by engaging in a scheme to improperly bill Medicare for laboratory tests.
October 4, 2023
Consumer genetic testing may misrepresent breast cancer risk: Study
By
Matt Limb
Women are being told they are at high risk of breast cancer from consumer genetic test results which do not take family history into account, say researchers.
September 21, 2023
Myriad Genetics, Memorial Sloan Kettering collaborate on MRD testing for breast cancer
By
LabPulse.com staff writers
Myriad Genetics is collaborating with Memorial Sloan Kettering Cancer Center to study the use of Myriad's minimal residual disease testing platform in predicting breast cancer treatment response.
September 18, 2023
Ibex Medical Analytics launches AI-powered breast cancer biomarker scoring platform
By
Matt Limb
Ibex Medical Analytics has launched a breast cancer biomarker scoring tool powered by artificial intelligence (AI) to help clinicians with treatment decisions.
September 11, 2023
NeoGenomics secures Medicare coverage for breast cancer blood test
By
Nick Paul Taylor
In the first quarter, NeoGenomics made the RaDaR test fully available to U.S. clinicians, having previously provided it for use in clinical research studies and pharmaceutical collaboration, and completed a filing to MolDx.
August 8, 2023
Page 1 of 13
Next Page
